Abiopharma

Canton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®

Silo Pharma SILO Notification

Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Update regarding a structural move in the holdings of the controlling shareholder in the company, details

Bond Secures Up to $3 Million in Non-Dilutive Insider Capital Through Renewal of Low Interest Credit Facility

Butterfly Network, Inc. - Butterfly Network Provides Commentary on Midjourney Medical’s Full Body Ultrasound Scanner Announcement

Butterfly Network Provides Commentary on Midjourney Medical’s Full Body Ultrasound Scanner Announcement

SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide

RedHill Biopharma - RedHill Biopharma Announces Up To $19.4 Million Private Placement

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026